Small-business R&D tax credit expanded, refundable against payroll taxes

What it does

This bill expands the federal research and development tax credit for small businesses by raising the gross-receipts threshold from $5 million to $10 million, allowing more companies to qualify; increasing the credit rate from 14% to 20% for eligible small firms; and making the credit refundable against payroll taxes (not just income taxes), so small businesses can receive cash refunds rather than just offsets. The changes take effect for tax years beginning after December 31, 2025.

Why we flagged it

The bill's operative mechanism is a targeted tax credit expansion—raising thresholds, increasing rates, and making credits refundable—designed to reduce the tax burden on small businesses engaged in research and development. This is a straightforward tax-incentive bill, not a subsidy or appropriation.

What the text implies

• Refundability against payroll taxes (§3301) converts the credit from a tax offset into a cash payment, increasing the fiscal cost and creating a new entitlement-like mechanism for qualifying businesses.
• The $10M gross-receipts threshold and expanded definition of 'qualified small business' may capture mid-market firms that are not typically considered 'small' in other federal programs, creating inconsistency in small-business definitions across tax law.
• Inflation adjustment mechanism (§41(h)(4)(ii)) will automatically increase dollar thresholds annually after 2026, potentially expanding eligibility over time without further legislative action.
• The bill does not require that R&D spending benefit U.S. workers or domestic innovation; foreign-owned subsidiaries and offshored R&D may qualify, limiting public-interest alignment.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Small businesses gain a tangible tax benefit that may reduce their effective cost of R&D investment and improve cash flow, potentially spurring innovation and job creation. However, the bill reduces federal tax revenue without offsetting spending cuts or revenue sources, shifting the fiscal burden to other taxpayers or future deficits; the benefit flows primarily to businesses with sufficient R&D capacity to claim the credit, not to workers or consumers directly.

Who stands to gain

• small and mid-market businesses with R&D expenditures
• technology and life-sciences companies
• manufacturing firms with in-house R&D

Named in the bill

Internal Revenue Code §41 (research credit), Internal Revenue Code §3111(f) (payroll tax credit), Internal Revenue Code §3301 (unemployment tax), Internal Revenue Code §448(c)(3) (gross receipts definition), House Committee on Ways and Means

Where it stands

• Aug 8, 2025 — Introduced · Congress.gov: “Introduced in House”
• Aug 8, 2025 — Referred to House Committee on Ways and Means · Congress.gov: “Referred to the House Committee on Ways and Means”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.